SARS-CoV-2 Antibodies in Adult Patients With Multiple Sclerosis in the Amsterdam MS Cohort.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 33929488.
- Also identified by DOI 10.1001/jamaneurol.2021.1364 and PMC identifier 8087977.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This cohort study assesses a group of patients with multiple sclerosis in Amsterdam, the Netherlands, for SARS-CoV-2 antibodies to quantify asymptomatic infections and immunological response to COVID-19.
Medical subject headings
- Antibodies, Viral
- COVID-19